LGP · ASX

Little Green Pharma Ltd. (ASX:LGP)

AU$0.11

 0.0 (0.0%)
ASX:Live
13/06/2025 04:10:38 PM
HALO Value HALO Ords GROWTH AUS Fakey Shakey - Long EMA 125 Breakdown +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

LGP Overview

LGP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

About LGP

Website

Little Green Pharma Ltd.

Telephone

61.8.6280.0050

Address

13A Bedbrook Place Shenton Park, Western Australia (WA) 6008

Description

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. Its medicines are cultivated, without pesticides, in a hydroponic facility. It operates through the Australia and Europe geographical segments. The company was founded in 2016 and is headquartered in West Perth, Australia.

LGP Price Chart

Key Stats

Market Cap

AU$33.44M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.08 - 0.17

Trade Value (12mth)

AU$8,679.00

1 week

-4.35%

1 month

0%

YTD

-15.38%

1 year

-4.35%

All time high

1.02

Key Fundamentals

EPS 3 yr Growth

-110.60%

EBITDA Margin

-0.90%

Operating Cashflow

-$1m

Free Cash Flow Return

-1.10%

ROIC

4.00%

Interest Coverage

-0.80

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

302m

HALO Sector

Industrials

Next Company Report Date

28-May-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

LGP Announcements

Latest Announcements

Date Announcements

11 June 25

FY2025 Annual Report Presentation

×

FY2025 Annual Report Presentation

10 June 25

FY2025 financial results - Investor webinar invitation

×

FY2025 financial results - Investor webinar invitation

30 May 25

Corporate Governance Statement and Appendix 4G

×

Corporate Governance Statement and Appendix 4G

30 May 25

Appendix 4E and 2025 Annual Report

×

Appendix 4E and 2025 Annual Report

13 May 25

March 2025 Quarterly & Appendix 4C Investor Presentation

×

March 2025 Quarterly & Appendix 4C Investor Presentation

07 May 25

Investor Webinar Invitation

×

Investor Webinar Invitation

30 April 25

Application for quotation of securities - LGP

×

Application for quotation of securities - LGP

30 April 25

Notification of cessation of securities - LGP

×

Notification of cessation of securities - LGP

30 April 25

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

04 April 25

QUEST Initiative 12-month results

×

QUEST Initiative 12-month results

02 April 25

French medicinal cannabis legislation defined

×

French medicinal cannabis legislation defined

20 March 25

Application for quotation of securities - LGP

×

Application for quotation of securities - LGP

04 March 25

Initial Directors Interest Notice x 2

×

Initial Directors Interest Notice x 2

04 March 25

Final Directors Interest Notice

×

Final Directors Interest Notice

04 March 25

Notification regarding unquoted securities - LGP

×

Notification regarding unquoted securities - LGP

04 March 25

Application for quotation of securities - LGP

×

Application for quotation of securities - LGP

03 March 25

LGP Board changes

×

LGP Board changes

11 February 25

December 2024 Quarterly Investor Presentation

×

December 2024 Quarterly Investor Presentation

10 February 25

Investor webinar invitation

×

Investor webinar invitation

06 February 25

LGP completes Health House acquisition

×

LGP completes Health House acquisition

05 February 25

LGP signs acquisition agreement for Health House

×

LGP signs acquisition agreement for Health House

31 January 25

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

20 December 24

LGP to acquire Health House distribution business

×

LGP to acquire Health House distribution business

19 December 24

Key changes to WA medicinal cannabis practices

×

Key changes to WA medicinal cannabis practices

05 December 24

Denmark positioned as EU medicinal cannabis hub

×

Denmark positioned as EU medicinal cannabis hub

LGP Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.03 0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.03 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 66.9 20.5 140.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 61.7 N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 20.7 N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.01 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.04 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 75.6 58.4 221.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -19.5 -1.5 -3.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 0.0 N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.28 0.26 0.28 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.26 0.25 0.27 Lock Lock Lock
     Growth % Lock Lock Lock Lock -15.3 -6.8 8.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 250 300 302 Lock Lock Lock
Basic m Lock Lock Lock Lock 250 300 302 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 20 26 37 Lock Lock Lock
     Growth % Lock Lock Lock Lock 41.4 29.1 43.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 22 11 11 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 8 2 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 76.3 -70.5 247.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 40.0 9.2 22.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 60 91 78 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -11 -6 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 57.6 51.9 94.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -57.7 -21.5 -0.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 3 3 4 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -14 -9 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 49.1 40.5 52.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -72.8 -33.5 -11.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -14 -10 -5 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -5 -1 -8 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -9 -8 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 64.4 4.7 140.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -43.1 -31.8 9.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -7 0 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 1 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -14 -3 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 13 -5 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -9 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 64.7 92.6 -77.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.4 -0.0 -0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 12 5 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 99 86 96 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 5 3 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 0 2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 16 9 11 Lock Lock Lock
Equity $m Lock Lock Lock Lock 82 77 85 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 88 80 87 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.3 -8.9 9.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -8.7 -9.4 3.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -10.4 -10.6 3.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -15.6 -9.7 -4.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -10.3 -9.7 4.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -8.3 0.1 -1.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -12.3 -8.7 -0.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.0 -0.0 -7.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -0.6 0.2 2.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.8 3.3 2.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.9 1.4 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 39.8 23.1 10.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -62.9 1.0 -10.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.1 4.7 10.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.3 2.0 2.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.0 1.7 2.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.3 6.0 10.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -68.9 -37.6 -13.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -13.9 -11.2 -5.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -8.7 -9.4 3.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -10.4 -10.6 3.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -10.4 -10.6 3.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 284.8 179.6 179.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 119.3 77.4 36.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 404.1 257.1 216.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 65.2 26.5 32.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 338.9 230.5 184.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

LGP Shortsell

Frequently Asked Questions

The current share price of Little Green Pharma Ltd. (LGP:ASX) is AU$0.11.
The 52-week high share price for Little Green Pharma Ltd. (LGP:ASX) is AU$0.17.
The 52-week low share price for Little Green Pharma Ltd. (LGP:ASX)? is AU$0.08.
Little Green Pharma Ltd. (LGP:ASX) does not pay a dividend.
Little Green Pharma Ltd. (LGP:ASX) does not pay a dividend.
Little Green Pharma Ltd. (LGP:ASX) has a franking level of 0.0%.
Little Green Pharma Ltd. (LGP:ASX) is classified in the Industrials.
The current P/E ratio for Little Green Pharma Ltd. (LGP:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.